ArticleExploration of targeted anti-tumor therapy2025

Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data.

Fabrizio Nelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.